메뉴 건너뛰기




Volumn 16, Issue 9, 2005, Pages 1458-1462

Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer

Author keywords

Letrozole; Q TWiST; Quality adjusted survival; Tamoxifen

Indexed keywords

LETROZOLE; TAMOXIFEN;

EID: 24044544601     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi275     Document Type: Article
Times cited : (22)

References (10)
  • 1
    • 0025866549 scopus 로고
    • Quality-of-life adjusted evaluation of adjuvant therapies for operable breast cancer
    • for the International Breast Cancer Study Group
    • Gelber RD, Goldhirsch A, Cavalli F, for the International Breast Cancer Study Group. Quality-of-life adjusted evaluation of adjuvant therapies for operable breast cancer. Ann Intern Med 1991; 114: 621-628.
    • (1991) Ann. Intern. Med. , vol.114 , pp. 621-628
    • Gelber, R.D.1    Goldhirsch, A.2    Cavalli, F.3
  • 2
    • 0027146570 scopus 로고
    • Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments
    • for the International Breast Cancer Study Group
    • Gelber RD, Goldhirsch A, Cole BF, for the International Breast Cancer Study Group. Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. Control Clin Trials 1993; 14: 485-499.
    • (1993) Control Clin. Trials , vol.14 , pp. 485-499
    • Gelber, R.D.1    Goldhirsch, A.2    Cole, B.F.3
  • 4
    • 0022873029 scopus 로고
    • A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer
    • for the Ludwig Breast Study Group
    • Gelber RD, Goldhirsch A, for the Ludwig Breast Study Group. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 1986; 4: 1772-1779.
    • (1986) J. Clin. Oncol. , vol.4 , pp. 1772-1779
    • Gelber, R.D.1    Goldhirsch, A.2
  • 5
    • 0024536390 scopus 로고
    • Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis
    • Goldhirsch A, Gelber RD, Simes RJ et al. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis. J Clin Oncol 1989; 7: 36-44.
    • (1989) J. Clin. Oncol. , vol.7 , pp. 36-44
    • Goldhirsch, A.1    Gelber, R.D.2    Simes, R.J.3
  • 7
    • 0343584508 scopus 로고    scopus 로고
    • Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer
    • Mouridsen H, Gershanovich M, Sun Y et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. J Clin Oncol 2001; 19: 2596-2606.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 2596-2606
    • Mouridsen, H.1    Gershanovich, M.2    Sun, Y.3
  • 8
    • 0038460245 scopus 로고    scopus 로고
    • Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group
    • Mouridsen H, Gershanovich M, Sun Y et al. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol 2003; 21: 2101-2109.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 2101-2109
    • Mouridsen, H.1    Gershanovich, M.2    Sun, Y.3
  • 9
    • 0037252456 scopus 로고    scopus 로고
    • Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework
    • Mounier N, Ferme C, Fletchner H et al. Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework. Med Decis Making 2003; 23: 54-66.
    • (2003) Med. Decis. Making , vol.23 , pp. 54-66
    • Mounier, N.1    Ferme, C.2    Fletchner, H.3
  • 10
    • 1542289007 scopus 로고    scopus 로고
    • A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer
    • Cole BF, Gelber RD, Gelber S, Mukhopadhyay P. A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer. J Biopharm Stat 2004; 14: 111-124.
    • (2004) J. Biopharm. Stat. , vol.14 , pp. 111-124
    • Cole, B.F.1    Gelber, R.D.2    Gelber, S.3    Mukhopadhyay, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.